We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Seeking to improve its drug discovery technology and establish a beachhead in
the fertile Cambridge biotechnology cluster, drug giant Schering-Plough of Kenilworth,
N.J., said it would buy NeoGenesis Pharmaceuticals of Cambridge for an undisclosed
sum.
Bolder BioTechnology has been awarded a $100,000 Phase I Small Business Innovation
Research (SBIR) grant from the National Institute of Arthritis and Musculoskeletal
and Skin Diseases (NIAMS) of NIH.
Solvay Pharmaceuticals has announced the successful
completion of the acquisition of Neopharma AB, a company based in Uppsala, Sweden,
as shareholders representing 100 percent of the company's capital accepted the
friendly takeover bid launched by Solvay last December.
To help speed the availability of innovative medical products, HHS should create
a forum that will enable investigators and developers to discuss their products
with key research, regulatory and reimbursement agencies, according to an HHS
task force report.
The controversy surrounding Pfizer's Cox-2 inhibitors, Celebrex and Bextra,
took a new turn when the company was cited by the FDA for making false and misleading
statements in advertisements for the painkillers.
The Combination Products Coalition (CPC) intends to submit a draft report to
the FDA with recommendations on how FDA intercenter agreements can be modified
to better define roles and responsibilities for handling approvals, modifications
and preapproval inspections for combination products.
Police want it. Drug companies don't. A lobbyist for OTC pharmaceutical companies
was the lone voice of opposition at a Senate Judiciary Committee hearing on
a law that would require pills used to make methamphetamine be sold behind a
pharmacist's counter.
Accredo Health has announced that one of its three primary divisions, Accredo
Therapeutics, has been selected by CoTherix as one of up to three specialty
pharmacy providers of Ventavis (iloprost) Inhalation Solution.
FemmePharma has announced two significant changes to its corporate structure
that will enable it to effectively play an expanded role in the growing worldwide
market for woman-focused pharmaceutical products.